Hannes Hagström

Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up

Mattias Ekstedt, Hannes Hagström, Patrik Nasr et al. · Hepatology · 2014 · 2.3K citations · Full text

Medicine, Internal Medicine, Pathology +17

Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD

Hannes Hagström, Patrik Nasr, Mattias Ekstedt et al. · Journal of Hepatology · 2017 · 1.1K citations

Medicine, Internal Medicine, Pathology +15

Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort

Tracey G. Simon, Björn Roelstraete, Hamed Khalili et al. · Gut · 2020 · 662 citations · Full text

Medicine, Internal Medicine, Pathology +16

Risk for development of severe liver disease in lean patients with nonalcoholic fatty liver disease: A long‐term follow‐up study

Hannes Hagström, Patrik Nasr, Mattias Ekstedt et al. · Hepatology Communications · 2017 · 311 citations · Full text

Medicine, Internal Medicine, Pathology +16

Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort

Tracey G. Simon, Björn Roelstraete, Hannes Hagström et al. · Gut · 2021 · 310 citations

Medicine, Internal Medicine, Epidemiologic Methods +16